MANGALAM DRUGS & ORGANICS
Intrinsic Value | Fundamental Analysis

BOM : 532637     NSE : MANGALAM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 25,2022
Price(EOD): β‚Ή 108.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 171.75 Cr
Value of β‚Ή 1 Lac invested in MANGALAM DRUGS & ORGANICS
on May 25,2017 (price: β‚Ή 178.65)

β‚Ή 1 L

β‚Ή 0.61 L

1W : -2.5% 1M : -12.1% 1Y : -20.1%
COMMUNITY POLL
for MANGALAM DRUGS & ORGANICS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
MANGALAM DRUGS & ORGANICS -2.5% -12.1% -20.1%
SUN PHARMACEUTICAL INDUSTRIES 3% 1.3% 31.9%
DIVIS LABORATORIES -16.2% -20.1% -9.3%
DR REDDYS LABORATORIES 9.6% 4.7% -16.9%
CIPLA 3.6% 1.9% 4.7%
GLAND PHARMA -11.4% -16.5% -9.6%
PIRAMAL ENTERPRISES -4.4% -14.3% 4.7%
CADILA HEALTHCARE 8.2% 7.4% -39.9%
TORRENT PHARMACEUTICALS 1.7% -3.5% -4.6%

FUNDAMENTAL ANALYSIS OF MANGALAM DRUGS & ORGANICS

 
Fundamentals Score
[ Q(TTM): Dec2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF MANGALAM DRUGS & ORGANICS

 
Valuation Score
[As on : May 25,2022 ]

Ratio Standalone
P/E
P/B
P/S
6.15
P/E Calculated based on EPS of 17.67
[ Mar2021 - Standalone Results ]

1.31
P/B Calculated based on Book Value of 82.74
[ Mar2021 - Standalone Results ]

0.43
P/S Calculated based on Revenues of 403.603 Cr
[ TTM - Standalone Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF MANGALAM DRUGS & ORGANICS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
208%
12%
148%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MANGALAM DRUGS & ORGANICS


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

MANGALAM DRUGS & ORGANICS vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MANGALAM DRUGS & ORGANICS

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.49
0.48
0.66
0.54
-
-
-
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MANGALAM DRUGS & ORGANICS

Pledged Promoter Shares
19.98 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MANGALAM DRUGS & ORGANICS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-17.83%
26.94%
8.11%
-11.16%
5.81%
-50.24%
-2.55%
-37.48%
QtrlyTrend
-2
Latest Qtr: Dec2021
Quarterly Result Analysis →


MANGALAM DRUGS & ORGANICS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about MANGALAM DRUGS & ORGANICS


Is MANGALAM DRUGS & ORGANICS good for long term investment?

As on May 25,2022, the Fundamentals of MANGALAM DRUGS & ORGANICS look Poor and hence it may not be good for long term investment ! See Financial Performance of MANGALAM DRUGS & ORGANICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MANGALAM DRUGS & ORGANICS UnderValued or OverValued?

As on May 25,2022, MANGALAM DRUGS & ORGANICS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MANGALAM DRUGS & ORGANICS ?

As on May 25,2022, the Intrinsic Value of MANGALAM DRUGS & ORGANICS is Rs. 43.87 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 35.29
Fair Value [Median EV / Sales Model] : Rs. 97.00
Fair Value [Median Price / Sales Model] : Rs. 43.87
Median Fair Value of MANGALAM DRUGS & ORGANICS : Rs. 43.87

Is MANGALAM DRUGS & ORGANICS trading at a Premium or Discount?

As on May 25,2022, MANGALAM DRUGS & ORGANICS is trading at a Premium of 148% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z